Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05259033 |
|---|---|
| Brief Title: | A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) (COMBINE 2) |
| First Submitted : | February 10, 2022 |
| First Submitted that Met QC Criteria : | February 17, 2022 |
| First Posted : | February 28, 2022 |
| Last Update Submitted that Met QC Criteria : | February 20, 2024 |
| Last Update Posted : | February 21, 2024 |